Sight Sciences Defeats Invalidity Challenges Filed By Alcon and Ivantis In The U.S. Patent Office
Sight Sciences Defeats Invalidity Challenges Filed By Alcon and Ivantis In The U.S. Patent Office
PDF Version MENLO PARK, Calif., March 30, 2023 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today reported that it defeated all four patent invalidity challenges filed by Alcon and Ivantis in […]
Sight Sciences Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Financial Results
MENLO PARK, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced preliminary unaudited financial results for the fourth quarter and year ended December 31, 2021. Preliminary and Unaudited 2021 Financial Results […]